Drugs / XW-LTH-03
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07333573 | Jan 2026 → Jun 2027 expected | gastric cancer | Shanghai Zhongshan Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | XW-LTH-03 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07333573 ↗ |
| Modality | Cell therapy | “novel hypoxia-inducible, bispecific CD73/AXL-targeting CAR-T cell product, XW-LTH-03” NCT07333573 ↗ |